Skip to main content
$2.11 -$0.05 (-2.3%)

02:13 PM EDT on 05/13/21

Marker Therapeutics Inc (NASDAQ:MRKR)

CAPS Rating: 1 out of 5

Current Price $2.11 Mkt Cap $179.3M
Open $2.23 P/E Ratio 0.00
Prev. Close $2.16 Div. (Yield) $0.00 (0.0%)
Daily Range $2.04 - $2.41 Volume 2,290,545
52-Wk Range $1.32 - $3.77 Avg. Daily Vol. 5,148,851

Caps

How do you think NASDAQ:MRKR will perform against the market?

Add Stock to CAPS Watchlist

All Players

9 Outperform
42 Underperform
 

All-Star Players

0 Outperform
20 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:MRKR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

LookMomBoogers (74.56)
Submitted March 23, 2018

Novel approach, taking a flyer

TMFStockSpam (27.77)
Submitted February 18, 2010

This stock spam was originally sent to TMFPhila:TapImmune Inc. Syimbol: TPIV Currrent Value: $0.47Shorrt Term Tarrget: $1.25Lonng Term Tarrget: $4.30TapImmune Inc. is a biotechnology company specializing in the development of innovative cell based… More

NASDAQ:MRKR VS S&P 500 (SPY)

NASDAQ:MRKR Summary

Fools bullish on NASDAQ:MRKR are also bullish on:

Fools bearish on NASDAQ:MRKR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MRKR.

Recs

0
Member Avatar CramersSkeeDaddy (80.86) Submitted: 10/17/2018 1:50:39 PM : Underperform Start Price: $8.12 NASDAQ:MRKR Score: +120.50

Doesn't add up, huge run up, nothing there. Probably a advertorial in the background touting how this dog gets to $1000 and cures the world of cancer. Gotta love those OTC - bulletin board issues that have a market cap over 100million and are up 200% over the last several months. Likely going to zero.

Recs

0
Member Avatar ChiefPaw (26.57) Submitted: 8/7/2018 2:41:59 AM : Underperform Start Price: $7.54 NASDAQ:MRKR Score: +116.17

junk

Recs

1
Member Avatar TMFStockSpam (27.77) Submitted: 2/18/2010 10:30:54 AM : Underperform Start Price: $552.00 NASDAQ:MRKR Score: +371.53

This stock spam was originally sent to TMFPhila:

TapImmune Inc.

Syimbol: TPIV

Currrent Value: $0.47
Shorrt Term Tarrget: $1.25
Lonng Term Tarrget: $4.30

TapImmune Inc. is a biotechnology company specializing in the development of innovative cell based immunotherapeutics and vaccines in the areas of cancer and infectious disease.
The Company's lead product candidate, the AdhTAP vaccine enhancer is designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system.

The Company is also developing a TAP based prophylactic vaccine which initial tests indicate may increase the efficacy of targeted prophylactic vaccines by up to 1000 times.

All eyes are going to be on this Winner with a Major Awareness campaign shifting into top gear.

Keep it on your radar!

Leaderboard

Find the members with the highest scoring picks in MRKR.

Score Leader

TMFStockSpam

TMFStockSpam (27.77) Score: +371.53

The Score Leader is the player with the highest score across all their picks in MRKR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFStockSpam 27.77 2/18/2010 Underperform NS $552.00 -99.62% +271.91% +371.53 1 Comment
patatepoil6 96.76 2/5/2016 Underperform 5Y $7.20 -70.69% +118.08% +188.78 0 Comment
evergreen5555 71.20 1/29/2016 1/26/2021 Underperform NS $7.20 -70.70% +116.51% +187.21 0 Comment
fps32 75.87 12/14/2015 Underperform 5Y $8.40 -74.88% +103.60% +178.48 0 Comment
JoeySolitro3 95.45 12/16/2015 Underperform 5Y $7.58 -72.18% +99.13% +171.31 0 Comment
NobleOrSomeBull 97.99 8/12/2016 Underperform 5Y $6.30 -66.51% +88.36% +154.87 0 Comment
Toprope101 99.81 8/9/2016 Underperform 5Y $6.24 -66.19% +88.23% +154.41 0 Comment
Dosada123 42.97 12/1/2016 Underperform 5Y $4.66 -54.72% +86.39% +141.11 0 Comment
TMFWillSommers 99.27 12/8/2016 Underperform 5Y $4.19 -49.64% +83.20% +132.84 0 Comment
yosemitebean 36.04 6/25/2018 Underperform 5Y $9.99 -78.88% +50.46% +129.34 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MRKR.